Results 161 to 170 of about 15,943 (285)

The evolving landscape of restrictive cardiomyopathy treatment: clinical trial trends and future directions. [PDF]

Front Cardiovasc Med
Deng B, Liu W.
europepmc   +1 more source

A muscular dystrophy associated with bi‐allelic LEMD2 variants: Expanding the genotype of nuclear envelopathies

Brain Pathology, EarlyView.
Proteomics‐guided exome re‐analysis identifies bi‐allelic variants in the nuclear envelope LEMD2 gene, expanding its phenotypic spectrum. Created in BioRender. Pauper, M. (2026) https://BioRender.com/xamvo92.
Marc Pauper, Heike Kölbel, Iakowos Karakesisoglou, Anne Schänzer, Johann Böhm, Rachel Thompson, Nicolai Kohlschmidt, Bernd Ringel, Gisèle Bonne, Katja Neuhoff, Andrea Gangfuß, Ozge Aksel Kilicarslan, Sergi Beltran Agullo, Andreas Hentschel, Ulrike Schara‐Schmidt, Hanns Lochmüller, Kiran Polavarapu, Andreas Roos   +17 more
wiley   +1 more source

Constrictive-effusive pericarditis and epicarditis as a cause of restrictive cardiomyopathy associated with Dirofilaria repens infection in a dog. [PDF]

BMC Vet Res
Szaluś-Jordanow O, Łobaczewski A, Jańczak D, Masny A, Kliczkowska K, Sapierzyński R, Zdeb K, Biernacka K, Gołąb E, Frymus T.   +9 more
europepmc   +1 more source

Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes [PDF]

, 2015
Petar Seferović, Walter J. Paulus
openalex   +1 more source

Non‐canonical PKG1 regulation in cardiovascular health and disease

British Journal of Pharmacology, EarlyView.
It is well established that the cyclic GMP‐dependent protein kinase I (PKG1) is canonically activated by cyclic guanosine monophosphate (cGMP), enabling its regulation of vascular tone, cardiac function and smooth muscle homeostasis. However, diverse non‐canonical stimuli of PKG1 have also been identified.
Jie Su, Joseph Robert Burgoyne
wiley   +1 more source

Clinical-genetic profiles and risk prediction model in childhood restrictive cardiomyopathy: a national cohort study of China. [PDF]

BMC Med
Chen H, Wang S, Quan J, Ding W, Liu C, Peng H, Wang J, Xiao Y, Li Z, Wang H, Gao L, Shi L, Li Y, Yang S, Zhang L, Huang Y, Liang P, Guo Q, Li J, Shan G, Zhang H, Liu X, Zhang H, Li W, Zhang B, Zhang C, Tong S, Chan W, Wang R, Zhang H, Han L, Lv T, Fu L.   +32 more
europepmc   +1 more source

Restrictive annuloplasty or replacement on reverse remodeling for nonischemic dilated cardiomyopathy [PDF]

Yusuke Misumi, Masashi Kawamura, Daisuke Yoshioka, Takuji Kawamura, Ai Kawamura, Yoshito Ito, Tsubasa Mikami, Masaki Taira, Kazuo Shimamura, Shigeru Miyagawa   +9 more
openalex   +1 more source

Songorine inhibits mitophagy in chronic heart failure via the TBC1D15/Fis1/Rab7A pathway

British Journal of Pharmacology, EarlyView.
Abstract Background and purpose Songorine (SGR) is an alkaloid extracted from Aconitum carichaelii Debx. and has a demonstrated role in cardiac dysfunction. Chronic heart failure (CHF) is a severe clinical syndrome leading to functional impairment and death, primarily due to the deterioration of energy metabolism in cardiomyocytes. However, the precise
Wenxiu Liu, Xingju Zou, Yang Zheng, Chen Sun, Cheng Peng   +4 more
wiley   +1 more source

Transient restrictive cardiomyopathy in cats: first reported case series. [PDF]

Front Vet Sci
Poissonnier C, Guigo P, Foulex P, Passavin P, Fouhety A, Douay T, Le Gall C, Kartout K, Bomassi É, Chetboul V.   +9 more
europepmc   +1 more source

The relationship between the cannabinoids and cardiac remodelling: A comprehensive review of pivotal mechanisms and emerging evidence

British Journal of Pharmacology, EarlyView.
Cardiac remodelling and fibrosis after myocardial infarction or during chronic diseases, such as arterial and pulmonary hypertension or diabetes mellitus, continue to be the more important prognostic factors in determining survival, and so the search for effective anti‐fibrotic interventions is an important target for research and therapy in cardiology.
Anna Krzyżewska, Marta Baranowska‐Kuczko, Hanna Kozłowska   +2 more
wiley   +1 more source